Clinical Research Facility in Miami, fl
Experience, expertise and facility to meet the individual needs of each sponsor and research protocol
The new Clinical Pharmacology of Miami (CPMI) research facility in Miami location was carefully considered. Our facility was meticulously custom designed and constructed with completion in 2025, employing all the knowledge of our experience. We have been told by our sponsors are convinced that our 150+ bed research unit is “State of the Art”. The facility is equipped with the experience and expertise to meet the individual needs of each sponsor and research protocol. The beautiful 75,000 square foot facility is a custom designed Clinical Pharmacology Research Unit.
Quality & Integrity
Clinical Pharmacology of Miami uses a validated environmental monitoring system to ensure the quality and integrity of all Cold rooms, pharmacy room temperatures, refrigerated / frozen drugs and samples stored within the CPMI research facility. Security Cameras are strategically placed throughout our clinical research facility in Miami, both inside and outside, to monitor and record all activity 24 hours a day, 7 days a week. The Facility has secure controlled and limited access to ensure both safety and security at all times.
Clinical Pharmacology of Miami is with a stand-by diesel generator that can power the facility. In the event of Power loss, the strong generator provides power to the facility. This includes but not limited to: all the refrigerators, freezers, centrifuges, and security monitoring equipment.
Clinical Pharmacology of Miami is protected by a stand-by natural gas generator that can power the entire facility. In the event of loss of Florida Power & Light power to the building, the strong, but quiet generator automatically detects the loss and starts providing power to the facility. This includes: all the refrigerators, freezers, centrifuges, and security monitoring equipment. The natural gas supply allows the generator to work without interruption for an extended period of time.
Since its inception, Clinical Pharmacology of Miami, has participated in approximately 1800 clinical studies of the safety and efficacy and mechanisms of action of Phase I, II and III drugs as well as bioavailability and pharmacokinetic studies in normal subjects as well as in special populations. Numerous clinical studies have been successfully audited by sponsoring institutions and by the Food and Drug Administration.
Virtually all studies have been conducted under auspices of active IND applications and approximately 60 successful NDA’s have contained data generated by these studies, including:
- Acrovastine
- Aalendronate
- Amiloride
- Amrinone
- Arbutamine
- Atenolol
- Benzazepril
- Candesartan Cilexetil
- Carteolol
- Caspofungin
- Ciprofloxacin
- Dofetilide
- Enalapril
- Encainide
- Eplerenone
- Recombinant Erythropoietin
- Etodolac
- Famotidine
- Felodipine
- Finasteride
- Flecanide
- Fosinopril
- Galantamine
- Grepafloxacin
- Indapamide
- Irbesartan
- Leucovorin
- Lisinopril
- Losartan
- Meropenem
- Milrinone
- Moexepril
- Montelukast
- Nefazodone
- Nimodipine
- Nisoldipine
- Nitroprusside
- Nizatidine
- Oxaprozin
- Penbutalol
- Pinacidil
- Piperacillin
- Piroxicam
- Prazosin
- Ramipril
- 13-Cis Retinoic Acid
- Rofecoxib
- Sinemet CR
- Sirolimus
- Sitagliptin
- Sulindac
- Sulindac
- Tegaserod
- Timolol
- Terazocin
- Tocanide
- Trandolapril
- Valsartan
- Venlafaxin
- Zafirlukast
- Zolmitriptan
- Zolpidem
- Acrovastine
- Aalendronate
- Amiloride
- Amrinone
- Arbutamine
- Atenolol
- Benzazepril
- Candesartan cilexetil
- Carteolol
- Caspofungin
- Ciprofloxacin
- Dofetilide
- Enalapril
- Encainide
- Eplerenone
- Recombinant erythropoietin
- Etodolac
- Famotidine
- Felodipine
- Finasteride
- Flecanide
- Fosinopril
- Galantamine
- Grepafloxacin
- Indapamide
- Irbesartan
- Leucovorin
- Lisinopril
- Losartan
- Meropenem
- Milrinone
- Moexepril
- Montelukast
- Nefazodone
- Nimodipine
- Nisoldipine
- Nitroprusside
- Nizatidine
- Oxaprozin
- Penbutalol
- Pinacidil
- Piperacillin
- Piroxicam
- Prazosin
- Ramipril
- 13-cis retinoic acid
- Rofecoxib
- Sinemet CR
- Sirolimus
- Sitagliptin
- Sulindac
- Tegaserod
- Timolol
- Terazocin
- Tocanide
- Trandolapril
- Valsartan
- Venlafaxin
- Zafirlukast
- Zolmitriptan
- Zolpidem
State-of-the-Art Clinical Research Facility in Miami, FL
- Screening Department / Interview / Exam Rooms / Prescreening lab & more
- Out-patient department
- Secure and monitored PK sample processing laboratory
- Secure temperature alarm monitored -20 and -80C freezers
- Secure alarm monitored pharmacy department
- Secure and monitored CRF / Record rooms
- Secure Entryways
- Standby Generator
- 120 clinical research beds
- 3 large PK rooms
- 6 private research rooms (2 plus beds each)
- Recreational activities planned for volunteers and access to a pool table
- Supervised Internet access areas for subjects
- Entire facility monitored by clinical staff, onsite 24 hours a day 7 days a week
- Security Video Monitor Recording 24 hours a day, 7 days a week
- Conference rooms
- Multiple monitor rooms with Internet, copier & phone
- Study coordinator / offices
- Ultrasounds contracted in for Women’s Health studies
- Data entry / regulatory affairs department
- Entire facility handicap accessible
- Onsite parking and use of Uber Health for subjects
- QTc Clinical trial ECG monitored research areas equipped with individual telemetry units